10/31/14 WAL 26.62 Western Alliance Bancorporation $WAL Hit

New Post Public Reply Private Reply Replies (0) Message Board

Nov 2, 2014 at 3:55 AM

10/31/14 WAL 26.62 Western Alliance Bancorporation $WAL Hit a 52 week high of 26.73 Closing the day 10/31/14 at 26.62 +0.53 +2.03% With a day low of 26.28 and a total volume of 744,300.

WAL Recent Posts: http://investorshangout.com/Western-Alliance-...WAL-53052/

WAL Western Alliance Bancorporation Recent Headline News

Will Western Alliance (WAL) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 8:07AM CDT
Will Western Alliance (WAL) Continue to Surge Higher?
WAL: 26.62 (+0.53)

Wells Fargo Sets Up Cleantech Innovation Incubator Program - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 6:20PM CDT
Wells Fargo (WFC), in a first ever kind of initiative in the banking domain, launched the Innovation Incubator program
WAL: 26.62 (+0.53), EBSB: 11.34 (+0.18), WFC: 53.09 (+0.63), GSBC: 38.01 (+0.94)

Can Western Alliance (WAL) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 7:38AM CDT
Since the recent estimates have been moving higher for Western Alliance, it has high chance of beating the estimates in the coming quarter.
WAL: 26.62 (+0.53)

BBCN Bancorp (BBCN) Falls: Stock Goes Down 5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 7:29AM CDT
BBCN Bancorp stock fell over 5% in the last trading session, falling below its one month volatile price range of $14.37 to $14.85
WAL: 26.62 (+0.53), GBNK: 15.77 (+0.11), BBNK: 24.12 (-0.38), BBCN: 14.14 (+0.28)

Upgrade Alert for Western Alliance Bancorp (WAL)
Comtex SmarTrend(R) - Tue Oct 21, 7:00AM CDT
Western Alliance Bancorp (NYSE:WAL) was upgraded from Neutral to Buy at Sterne Agee today. The stock closed yesterday at $24.35 on volume of 976,000 shares, above average daily volume of 406,000. In the past 52 weeks, shares of Western Alliance Bancorp have traded between a low of $20.56 and a high of $25.75 and closed yesterday at $24.35, which is 18% above that low price. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 0.2%.
WAL: 26.62 (+0.53)

How Will Western Alliance (WAL) Stock React Today to This Ratings Upgrade?
at The Street - Mon Oct 20, 7:50AM CDT
Western Alliance (WAL) was upgraded to 'buy' from 'neutral' at Sterne Agee.
WAL: 26.62 (+0.53)

Western Alliance Reports Third Quarter 2014 Net Income of $40.9 million, or $0.46 Per Share
Business Wire - Thu Oct 16, 3:49PM CDT
Western Alliance Bancorporation (NYSE:WAL) announced today its financial results for the third quarter 2014.
WAL: 26.62 (+0.53)

Western Alliance Bancorporation Announces Third Quarter 2014 Earnings Release Date, Conference Call and Webcast
Business Wire - Thu Oct 02, 1:10PM CDT
Western Alliance Bancorporation (NYSE: WAL) announced today that it plans to release its third quarter 2014 financial results after the market closes on Thursday, October 16, 2014. Chairman and CEO Robert Sarver and CFO Dale Gibbons will host a conference call at 12:00 p.m. ET on Friday, October 17, 2014, to discuss the Company's performance.
WAL: 26.62 (+0.53)

MELI, ATHN, EPI, IPCM, IRY, WAL Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Sep 12, 5:24AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of MercadoLibre Inc (NASDAQ:MELI), Athenahealth Inc (NASDAQ:ATHN), WisdomTree India Earnings Fund (NYSE:EPI), IPC The Hospitalist Co Inc (NASDAQ:IPCM), Spdr S&P International Health Care Sector Etf (NYSE:IRY), Western Alliance Bancorporation (NYSE:WAL) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
WAL: 26.62 (+0.53), IPCM: 41.66 (+0.02), EPI: 23.21 (+0.37), MELI: 136.15 (+20.95), IRY: 48.36 (+0.41), ATHN: 122.50 (+2.16)

Have American Consumers Become Snobs?
at The Street - Sun Aug 17, 7:00AM CDT
As U.S. spenders abandon Walmart, Budweiser, McDonald's and the Olive Garden for Nordstrom Rack, Blue Moon, Chipotle and Capital Grille, value becomes key.
BUD: 110.98 (+0.97), PNRA: 161.64 (-0.71), WAL: 26.62 (+0.53), CMG: 638.00 (-1.68), MCD: 93.73 (+0.35), JWN: 72.61 (+0.20), COST: 133.37 (+0.37), DRI: 51.78 (+0.60)

Why Western Alliance Bancorporation (WAL) Stock Might be a Great Pick - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 7:47AM CDT
Western Alliance Bancorporation is seeing solid earnings estimate revision activity and is a great company from a Zacks Industry Rank perspective.
WAL: 26.62 (+0.53)

Insider Trading Alert - REX, WAL And PANW Traded By Insiders
at The Street - Fri Jul 25, 9:04AM CDT
Stocks with insider trader activity include REX, WAL and PANW
WAL: 26.62 (+0.53), REX: 72.76 (+2.46), PANW: 105.70 (+0.77)

Western Alliance Reports Second Quarter 2014 Net Income of $35.5 Million, or $0.40 Per Share
Business Wire - Thu Jul 17, 3:31PM CDT
Western Alliance Bancorporation (NYSE:WAL) announced today its financial results for the second quarter 2014.
WAL: 26.62 (+0.53)

Western Alliance Bancorporation Announces Second Quarter 2014 Earnings Release Date, Conference Call and Webcast
Business Wire - Wed Jul 02, 10:36AM CDT
Western Alliance Bancorporation (NYSE: WAL) announced today that it plans to release its second quarter 2014 financial results after the market closes on Thursday, July 17, 2014. Chairman and CEO Robert Sarver and CFO Dale Gibbons will host a conference call at 12:00 p.m. ET on Friday, July 18, 2014 to discuss the Company's performance.
WAL: 26.62 (+0.53)

Fifth Third Raises Q2 Dividend by 8.3% - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 18, 5:30PM CDT
Fifth Third (FITB) has announced a cash dividend of 13 cents per common share for second-quarter 2014.
CVBF: 15.78 (+0.28), FITB: 19.99 (+0.26), WAL: 26.62 (+0.53), VNTV: 30.92 (+0.26)

Balanced View on Morgan Stanley - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 12, 10:00AM CDT
On Jun 6, 2014, we issued an updated research report on Morgan Stanley (MS).
BOFI: 77.02 (+3.97), CVBF: 15.78 (+0.28), WAL: 26.62 (+0.53), MS: 34.95 (+0.43)

Updated Research Report on Fifth Third - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 12, 9:50AM CDT
On Jun 6, 2014, we issued an updated research report on Fifth Third Bancorp (FITB). This regional bank recently reported lower-than-expected results due to lower non-interest income and higher provisions for credit losses, partially offset by declining expenses.
BOFI: 77.02 (+3.97), CVBF: 15.78 (+0.28), FITB: 19.99 (+0.26), WAL: 26.62 (+0.53)

Regional, Thrift Banks Are Seen Picking Up M&A Deals
at Investor's Business Daily - Mon Mar 31, 10:15AM CDT
M&A activity among regional banks is off to a "warmer" start this year vs. the prior two years as struggling banks look for ways to increase shareholder value, according to a new analyst report. Sterne Agee analyst Brett Rabatin notes that 28...
BHLB: 25.78 (+0.43), WAL: 26.62 (+0.53), ABCB: 24.80 (+0.10), FISI: 25.14 (+0.21), UBSI: 34.28 (-0.03), OZRK: 35.24 (+0.34), UMPQ: 17.60 (+0.35), HOMB: 31.92 (+0.60), IBKC: 68.86 (+1.46), HTH: 22.03 (+0.23), CHCO: 44.99 (+0.59), PB: 60.39 (+0.90), SCBT: 60.67 (+0.99)

Pressure on Pharmacies to Break Up With Big Tobacco Increases
Rupert Hargreaves, The Motley Fool - Motley Fool - Wed Mar 26, 10:30AM CDT
CVS ' recent well-publicized decision to stop selling tobacco products in its stores was done for all the right reasons from a health perspective. The company believes that the move will cost it around $2 billion in annual sales, which is less than...
WAL: 26.62 (+0.53), CVS: 85.81 (+0.26), MO: 48.34 (+0.84), RAD: 5.25 (+0.07)

Western Alliance Bancorporation (WAL) Stock Research Links

WAL Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Revamping Children's Radiotherapy: Leo Cancer Care's Vision

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Quay Shines in 2026 Prescription Sunglasses Lineup

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

DKS Facing Class Action Over Stock Slump Allegations

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Accuray, Samsung Push Boundaries with Imaging Deal

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Melrose Fire Station Reaches Steel Topping Milestone

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Fuse Oncology Showcases New iRT Workflow at ASTRO

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

AI Memory Growth Pushes Limits at GMIF2026 Summit

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Leo Cancer Care's Upright Radiotherapy Milestone

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

IASO's FUCASO Shows Robust Results in 2026 Study

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...